Starget Pharma
PrivateLast Round
Series A
Feb 18, 2026
Total Funding Raised
$33.1M
Company Overview
Starget Pharma is a biotechnology company that is a clinical stage developer of a pipeline of radioligand therapy programs generated using its proprietary Backbone Dynamics peptide platform that leverages backbone cyclic innovations and in-silico AI to rapidly design highly specific Smart Targeted Radioligands (STRs) that deliver focused radiation for the imaging and treatment of hard-to-treat cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Starget Pharma Comps
Public and private peers based on sector, stage, and business model.
Starget Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 18, 2026 | ||||
| Series A Extension | Oct 23, 2024 | ||||
| Series A | Nov 30, 2021 |
Starget Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cancer Focus Fund | Series A, Series A Extension |
| Biomedical Research Foundation of Northwest Louisiana | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 18, 2026
$18M round completed.
- Feb 18, 2026
Developing next-gen peptide radioligand therapies with CMIT collaboration.
Starget Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Starget Pharma's valuation, stock price, and market status.
